A recent General Practice digest,
as sent to subscribers

Study Type: Randomised controlled trial (1:1, single journal, authors unaware of the study; outcome assessors masked)

Key Question: Does giving authors a SPIRIT 2025-based manuscript template during revision improve completeness of reporting in randomised trial protocols?

Key Findings:

• Completeness of reporting (0–10 scale, 11 SPIRIT items) improved by an adjusted 0.61 points more with the template (95% CI 0.20 to 1.01); mean scores rose from 5.42 to 6.70 (intervention) versus 5.77 to 6.32 (control), n=70.
• Greatest gains were in recruitment, data collection methods, and data access; median revision time was similar (27.1 vs 29.9 days).
• Of 14 survey respondents (40%), most found the template easy to use (77%) and helpful (69%), but 62% found it time-consuming.

Clinical Relevance: Better-reported protocols support critical appraisal and reduce selective reporting, which matters for GPs designing or participating in NIHR-funded primary care trials and relying on published trial evidence.

Limitations: Small, single-journal sample with only a modest absolute improvement, a low survey response rate, no harms data, and no assessment of clinical or downstream research outcomes.

Study Type: Stepped wedge cluster randomised controlled trial (open label), 18 Dutch community hospitals.

Key Question: Does adding acetic acid chromoendoscopy (AAC) to standard Barrett's oesophagus surveillance increase detection of dysplasia and oesophageal adenocarcinoma?

Key Findings:

• Neoplasia detection rate was similar: 7.4% (50/679) with AAC vs 7.1% (113/1588) without (adjusted OR 0.97, 95% CI 0.65 to 1.44).
• AAC more than doubled detection of suspected lesions (14.0% vs 6.4%, P<0.001), but targeted neoplasia detection did not improve (2.1% vs 1.8%; OR 1.05, 95% CI 0.49 to 2.24).
• Of 2267 participants, 82% of those allocated to AAC received it; 163 (7.2%) had neoplasia overall (mostly low grade dysplasia).

Clinical Relevance: AAC offers no demonstrable diagnostic yield gain in routine non-tertiary surveillance, so it should not be expected to improve outcomes or justify added procedure time and training in NHS Barrett's surveillance services.

Limitations: Open label design with unequal allocation (63% control vs 37% AAC) and non-universal AAC uptake, with the wide confidence interval leaving modest benefit or harm unexcluded.

Study Type: Cross-sectional patient survey (British Columbia, Canada) with multivariable linear regression.

Key Question: How do patients experience shared decision making (SDM) with primary care clinical pharmacists, and what factors are associated with those experiences?

Key Findings:

• Of 2,714 patients invited, 604 completed the SDM-Q-9 (median score 77.8/100, IQR 62.2–91.1), indicating moderately strong agreement that SDM occurred.
• Unadjusted scores were higher in patients under 65 and those seen in person.
• In adjusted models, demographic and clinical factors explained little variance (adjusted R² 0.05). Psychological factors (expectations of the pharmacist, medication understanding, overall experience) explained most (R² 0.39).

Clinical Relevance: As UK practices expand ARRS-funded clinical pharmacist roles, these findings suggest pharmacist consultations can support collaborative medication decisions across patient groups, though patient expectations and understanding appear central to how SDM is experienced.

Limitations: Low response rate (about 30%) and self-selection of respondents introduce bias risk, and the Canadian model may not translate directly to NHS settings; the cross-sectional design also precludes causal inference.

Study Type: Commentary / perspective piece (not original research). No data collection or analysis described in the abstract.

Key Question: How does institutional compliance with US anti-DEI executive orders create moral distress for physicians and educators, and how might it be addressed?

Key Findings:

• The authors argue that conflict between ethical duties to patients and learners and compliance with anti-DEI directives (issued since January 2025) may be causing moral distress among clinicians and educators.
• They outline the concept of moral distress and propose individual- and organisation-level strategies, described as evidence-based, though the abstract cites no specific evidence or effect sizes.
• Content reflects the authors' personal viewpoints; no empirical findings are reported.

Clinical Relevance: Limited direct applicability to UK general practice, as the policy context is specific to the US; however, the moral distress framework and proposed coping strategies may be transferable to NHS settings where clinicians face tension between institutional constraints and patient advocacy.

Limitations: Not applicable (opinion-based paper); readers should note the absence of empirical data and the US-specific political context.

Study Type: Perspective/commentary (author's policy experience); not original research. No data, methods or formal analysis described.

Key Question: Why has meaningful reform of the US Medicare physician payment system repeatedly failed despite broad agreement that the current system is unstable?

Key Findings:

• The author argues that political, fiscal and procedural barriers, rather than lack of consensus on the problem, impede legislative action.
• Repeated temporary fixes create an "illusion of inaction", leaving the underlying payment structure unresolved.
• The author concludes that lasting reform requires a predictable, sustainable payment system. No quantitative evidence is presented in the abstract.

Clinical Relevance: Limited direct relevance to UK general practice, as this concerns US Medicare fee-for-service policy; it may offer indirect parallels to NHS contract negotiations and recurrent short-term funding settlements.

Limitations: Not applicable to a commentary, though the abstract reflects a single author's experience and US-specific context.

Study Type: Qualitative study (semi-structured patient interviews, thematic analysis)

Key Question: How do ambient AI scribes affect patient experience in ambulatory care, and what influences patient comfort with them?

Key Findings:

• Twenty patients across ambulatory specialties (including dermatology and primary care) were interviewed to thematic saturation. They reported fewer clinician distractions, more thorough visit notes, and more time for their questions.
• Comfort was linked to prior exposure to similar technology, the device being unobtrusive, absence of privacy concerns, a good existing patient-clinician relationship, and anticipated care benefits.
• No quantitative outcomes or effect sizes were reported.

Clinical Relevance: As ambient AI scribes are piloted in UK general practice, these findings suggest patient acceptability may depend on relationship continuity and addressing privacy concerns, which should inform consent and communication approaches.

Limitations: Small sample from a single US academic medical centre, with patients of clinicians already in a scribe trial, limiting transferability to NHS primary care and risking selection bias towards favourable views.

Study Type: Systematic scoping review (PubMed and EMBASE, 2020–2024; high-income countries including UK).

Key Question: Which interventions and implementation strategies effectively integrate smoking and vaping cessation support into primary care?

Key Findings:

• 30 empirical studies included from 2166 records screened; only two addressed e-cigarette/vaping cessation.
• Strongest evidence supported multi-component interventions combining behavioural counselling with pharmacotherapy. Supportive implementation strategies included EHR prompts, cost-free pharmacotherapy, financial incentives, and linking cessation to lung screening or post-spirometry feedback.
• Evidence for provider education alone was inconclusive.

Clinical Relevance: Supports combined behavioural and pharmacological approaches and systems-level prompts (e.g., template alerts, linkage to NHS lung cancer screening) in practice, but offers little guidance on managing vaping cessation.

Limitations: As a scoping review, it does not appear to have formally appraised study quality or pooled effect sizes, so strength-of-evidence statements are descriptive and the abstract gives no quantitative outcomes.

Study Type: Qualitative study (four virtual focus groups, thematic analysis)

Key Question: How do practising physicians conceptualise, develop and experience humanistic practice, and what helps or hinders it?

Key Findings:

• Participants (n=26, multiple specialties, 15 US states) viewed humanistic practice as relational and inseparable from competent care, developed mainly through relationships with patients, mentors and role models; these relationships also supported resilience.
• Definitions of humanistic practice were ambiguous, and participants reported marked tension with system priorities of efficiency, standardisation and commercialisation (e.g., relative value unit-driven models).
• Some described medical training culture and pedagogy as "damaging" to their innate humanism.

Clinical Relevance: The findings resonate with UK concerns about continuity, time pressure and burnout in general practice, and suggest that protecting mentorship and relational continuity may support both care quality and clinician retention.

Limitations: Small, self-selected US sample from a single time point (2023), so transferability to NHS settings is uncertain and no outcomes were linked to patient care.